Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel D. Von Hoff
Phase I Study of CC-486 Alone and in Combination With Carboplatin or Nab‑paclitaxel in Patients With Relapsed or Refractory Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
Quality of Life in Metastatic Pancreatic Cancer Patients Receiving Liposomal Irinotecan Plus 5-Fluorouracil and Leucovorin
European Journal of Cancer
Cancer Research
Oncology
Cyr61/Ccn1 Regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Characterization of a Membrane-Active Anti-Tumor Agent, UA8967
Investigational New Drugs
Oncology
Pharmacology
Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer
Cancer Journal
Cancer Research
Oncology
Progression-Free Survival Decreases With Each Subsequent Therapy in Patients Presenting for Phase I Clinical Trials
Journal of Cancer
Oncology
The Impact of Concomitant Medication Use on Patient Eligibility for Phase I Cancer Clinical Trials
Journal of Cancer
Oncology
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment With Erlotinib
Clinical Genitourinary Cancer
Oncology
Urology
Asparagine Synthetase as a Causal, Predictive Biomarker for L-Asparaginase Activity in Ovarian Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
1
2
›